Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Gurses Rabia Ozden > Profile

Gurses Rabia Ozden

Affiliations

  • Chief Medical Officer at Adverum Biotechnologies Inc. (ADVM), 2025-06-20
  • Chief Medical Officer at Ocular Therapeutix Inc (OCUL), 2024-02-06
  • Chief Development Officer at Akouos Inc. (AKUS), 2020-06-25
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OCUL $4.86 6,346 $30,841.56 153,054 2024-02-05 Filing
OCUL $4.95 7,764 $38,431.80 92,767 2024-01-31 Filing
OCUL $4.93 832 $4,101.76 100,531 2023-07-07 Filing
OCUL $4.24 6,416 $27,203.84 101,363 2023-02-06 Filing